Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 67

1.

Clinical characteristics of fatigued Parkinson's patients and the response to dopaminergic treatment.

Fu R, Luo XG, Ren Y, He ZY, Lv H.

Transl Neurodegener. 2016 May 10;5:9. doi: 10.1186/s40035-016-0056-2. eCollection 2016.

2.

New insight into the therapeutic role of the serotonergic system in Parkinson's disease.

Ohno Y, Shimizu S, Tokudome K, Kunisawa N, Sasa M.

Prog Neurobiol. 2015 Nov;134:104-21. doi: 10.1016/j.pneurobio.2015.09.005. Epub 2015 Oct 9. Review.

PMID:
26455457
3.

Depression.

Schulz PE, Arora G.

Continuum (Minneap Minn). 2015 Jun;21(3 Behavioral Neurology and Neuropsychiatry):756-71. doi: 10.1212/01.CON.0000466664.35650.b4. Review.

PMID:
26039852
4.

Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease.

Sandoval-Rincón M, Sáenz-Farret M, Miguel-Puga A, Micheli F, Arias-Carrión O.

Front Neurol. 2015 Mar 31;6:71. doi: 10.3389/fneur.2015.00071. eCollection 2015. Review.

5.

Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.

Weintraub D, Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Siderowf A, Aarsland D, Barone P, Burn D, Chahine LM, Eberling J, Espay AJ, Foster ED, Leverenz JB, Litvan I, Richard I, Troyer MD, Hawkins KA; Parkinson's Progression Markers Initiative.

Mov Disord. 2015 Jun;30(7):919-27. doi: 10.1002/mds.26170. Epub 2015 Mar 4.

6.

A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson's disease patients.

Xie CL, Wang XD, Chen J, Lin HZ, Chen YH, Pan JL, Wang WW.

Neurol Sci. 2015 Jun;36(6):833-43. doi: 10.1007/s10072-015-2118-0. Epub 2015 Feb 28. Review.

PMID:
25724804
7.

Depression in Parkinson's disease.

Rihmer Z, Gonda X, Döme P.

Ideggyogy Sz. 2014 Jul 30;67(7-8):229-36. Review.

PMID:
25509363
8.

Managing depression in Parkinson's patients: risk factors and clinical pearls.

Biemiller R, Richard IH.

Neurodegener Dis Manag. 2014;4(4):329-36. doi: 10.2217/nmt.14.31. Review.

PMID:
25313989
9.

Effects of sleep disorders on the non-motor symptoms of Parkinson disease.

Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S.

J Clin Sleep Med. 2013 Nov 15;9(11):1119-29. doi: 10.5664/jcsm.3148.

10.

Depression and Parkinson's disease: current knowledge.

Marsh L.

Curr Neurol Neurosci Rep. 2013 Dec;13(12):409. doi: 10.1007/s11910-013-0409-5. Review.

11.

Clinical issues in the treatment of anxiety and depression in older adults with Parkinson's disease.

Pachana NA, Egan SJ, Laidlaw K, Dissanayaka N, Byrne GJ, Brockman S, Marsh R, Starkstein S.

Mov Disord. 2013 Dec;28(14):1930-4. doi: 10.1002/mds.25689. Epub 2013 Oct 9. Review.

PMID:
24123116
12.

Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.

Maier F, Lewis CJ, Horstkoetter N, Eggers C, Kalbe E, Maarouf M, Kuhn J, Zurowski M, Moro E, Woopen C, Timmermann L.

J Neurol Neurosurg Psychiatry. 2013 Nov;84(11):1273-81. doi: 10.1136/jnnp-2012-303670. Epub 2013 May 28.

PMID:
23715910
13.

Psychiatric syndromes in Parkinson's disease.

Starkstein SE, Brockman S, Hayhow BD.

Curr Opin Psychiatry. 2012 Nov;25(6):468-72. doi: 10.1097/YCO.0b013e3283577ed1. Review.

PMID:
22992542
14.

Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.

McDermott CL, Gray SL.

Ann Pharmacother. 2012 Apr;46(4):599-605. doi: 10.1345/aph.1Q445. Epub 2012 Mar 13. Review.

PMID:
22414791
15.

Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson's disease.

Dobkin RD, Rubino JT, Allen LA, Friedman J, Gara MA, Mark MH, Menza M.

J Consult Clin Psychol. 2012 Aug;80(4):694-9. doi: 10.1037/a0027695. Epub 2012 Mar 12.

16.
17.

A new (old) treatment option for depression in Parkinson's disease.

Black KJ.

Am J Psychiatry. 2011 Oct;168(10):1015-6. doi: 10.1176/appi.ajp.2011.11071124. No abstract available.

PMID:
21969043
18.

Deep brain stimulation emerging indications.

Tierney TS, Sankar T, Lozano AM.

Prog Brain Res. 2011;194:83-95. doi: 10.1016/B978-0-444-53815-4.00015-7. Review.

PMID:
21867796
19.

Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial.

Dobkin RD, Menza M, Allen LA, Gara MA, Mark MH, Tiu J, Bienfait KL, Friedman J.

Am J Psychiatry. 2011 Oct;168(10):1066-74. doi: 10.1176/appi.ajp.2011.10111669. Epub 2011 Jun 15.

20.

The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.

Leentjens AF.

Drugs. 2011 Feb 12;71(3):273-86. doi: 10.2165/11585380-000000000-00000. Review.

PMID:
21319866
Items per page

Supplemental Content

Loading ...
Write to the Help Desk